These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 2892540
21. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Gilbert F, Brazell C, Tricklebank MD, Stahl SM. Eur J Pharmacol; 1988 Mar 15; 147(3):431-9. PubMed ID: 2897920 [Abstract] [Full Text] [Related]
22. Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine. Winter JC. Pharmacol Biochem Behav; 1988 Jan 15; 29(1):193-5. PubMed ID: 2895479 [Abstract] [Full Text] [Related]
23. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin. Marsden CA, Martin KF. Br J Pharmacol; 1986 Oct 15; 89(2):277-86. PubMed ID: 2430656 [Abstract] [Full Text] [Related]
24. Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat. Higgins GA, Bradbury AJ, Jones BJ, Oakley NR. Neuropharmacology; 1988 Oct 15; 27(10):993-1001. PubMed ID: 2467224 [Abstract] [Full Text] [Related]
25. Benzodiazepines and putative 5-HT1A agonists increase hypertonic saline consumption in rehydrating rats. Cooper SJ, Desa A. Pharmacol Biochem Behav; 1987 Oct 15; 28(2):187-91. PubMed ID: 2825218 [Abstract] [Full Text] [Related]
26. Brainstem 5-hydroxytrytamine1A binding sites are not down-regulated by agonists which induce tolerance in the rat: myoclonus and other serotonergic behaviors. Murthy JN, Pranzatelli MR. J Recept Res; 1992 Oct 15; 12(3):287-97. PubMed ID: 1387164 [Abstract] [Full Text] [Related]
27. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. de Boer SF, Lesourd M, Mocaer E, Koolhaas JM. J Pharmacol Exp Ther; 1999 Mar 15; 288(3):1125-33. PubMed ID: 10027850 [Abstract] [Full Text] [Related]
28. Antidepressant-like effects of alnespirone (S 20499) in the learned helplessness test in rats. Mac Sweeney CP, Lesourd M, Gandon JM. Eur J Pharmacol; 1998 Mar 19; 345(2):133-7. PubMed ID: 9600628 [Abstract] [Full Text] [Related]
29. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ, Bervoets K, Colpaert FC. J Pharmacol Exp Ther; 1991 Mar 19; 256(3):973-82. PubMed ID: 1826033 [Abstract] [Full Text] [Related]
30. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Goodwin GM, De Souza RJ, Green AR. Psychopharmacology (Berl); 1987 Mar 19; 91(4):500-5. PubMed ID: 2954178 [Abstract] [Full Text] [Related]
31. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools. Kalkman HO, Soar J. Eur J Pharmacol; 1990 Dec 04; 191(3):383-90. PubMed ID: 2150821 [Abstract] [Full Text] [Related]
32. The interoceptive discriminative stimuli induced by the novel putative anxiolytic TVX Q 7821: behavioral evidence for the specific involvement of serotonin 5-HT1A receptors. Spencer DG, Traber J. Psychopharmacology (Berl); 1987 Dec 04; 91(1):25-9. PubMed ID: 2881318 [Abstract] [Full Text] [Related]
33. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S. Eur J Pharmacol; 1984 Oct 15; 105(3-4):365-8. PubMed ID: 6239785 [Abstract] [Full Text] [Related]
34. Blockade of the anxiolytic-like action of ipsapirone and buspirone, but not that of 8-OH-DPAT, by adrenalectomy in male rats. López-Rubalcava C, Cruz SL, Fernández-Guasti A. Psychoneuroendocrinology; 1999 May 15; 24(4):409-22. PubMed ID: 10341368 [Abstract] [Full Text] [Related]
35. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? Jolas T, Schreiber R, Laporte AM, Chastanet M, De Vry J, Glaser T, Adrien J, Hamon M. J Pharmacol Exp Ther; 1995 Feb 15; 272(2):920-9. PubMed ID: 7853210 [Abstract] [Full Text] [Related]
36. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Kennett GA, Marcou M, Dourish CT, Curzon G. Eur J Pharmacol; 1987 Jun 12; 138(1):53-60. PubMed ID: 2442002 [Abstract] [Full Text] [Related]
37. Effects of ipsapirone and BAY R 1531 on learned helplessness. Graeff EO, Hunziker MH, Graeff FG. Braz J Med Biol Res; 1989 Jun 12; 22(9):1141-4. PubMed ID: 2636009 [Abstract] [Full Text] [Related]
38. Selective activation of 5HT1A receptors induces lower lip retraction in the rat. Berendsen HH, Jenck F, Broekkamp CL. Pharmacol Biochem Behav; 1989 Aug 12; 33(4):821-7. PubMed ID: 2533357 [Abstract] [Full Text] [Related]
39. Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics. Cunningham KA, Callahan PM, Appel JB. Eur J Pharmacol; 1987 Jun 12; 138(1):29-36. PubMed ID: 2887435 [Abstract] [Full Text] [Related]